Zentek Provides Update on Nasdaq Listing
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Zentek (TSXV: ZEN, NASDAQ: ZTEK) announced that its common shares are expected to transition from trading on the Nasdaq Capital Market to the OTC Markets Group on Tuesday, September 2, 2026, following a Nasdaq notice that its shares will be delisted for not meeting the minimum bid price requirement.
Zentek plans to request a Nasdaq hearing to appeal the delisting, but the hearing will not prevent trading suspension on Nasdaq, which is expected at the open on September 2, 2026. The company’s common shares will continue to trade on the TSX Venture Exchange, its primary listing, under symbol ZEN. Zentek has applied to have its shares quoted on the OTCQX Best Market and, according to the company, does not expect the transition to OTC Markets to materially impact its business or operations.
Positive
- TSX Venture Exchange primary listing under ZEN remains unaffected
- Application submitted for quotation on OTCQX Best Market
- Company states transition to OTC Markets not expected to materially impact operations
- Zentek intends to appeal Nasdaq delisting through a hearing process
Negative
- Nasdaq Capital Market delisting due to minimum bid price non-compliance
- Trading on Nasdaq expected to be suspended at open on September 2, 2026
- Move from Nasdaq to OTC Markets may reduce U.S. exchange visibility
Details
Market move: ZTEK -6.48% in the Aug 31 session. Nasdaq delisting update
On Aug 31, the first trading day after this news, ZTEK closed 6.48% below the previous close. Argus tracked a peak move of +48.2% during that session. Argus tracked a trough of -5.6% from its starting point during tracking. Our momentum scanner recorded 13 alerts for this stock that day. Relative volume reached 135.7x the daily average during tracking.
Data tracked by StockTitan Argus for the Aug 31 session.
Key Figures
- OTC Markets transition date
- September 2, 2026
- Nasdaq Capital Market transition
- Nasdaq trading suspension date
- September 2, 2026
- Expected at the open of trading
Historical Context
-
Government standing offer with published maximum value of CAD $348,666.84
-
Provisional patent filing introduced laboratory-stage electromagnetic shielding coating with unverified preliminary results
-
Preliminary economic assessment reported US$3.85 billion after-tax NPV and 27.4% IRR
-
Investor-relations engagement added North American outreach services for monthly cash compensation
-
Company-sponsored research coverage began under an 18-month compensated engagement
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
minimum bid price requirement regulatory
otcqx best market financial
form 8-k regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
Guelph, Ontario--(Newsfile Corp. - August 28, 2026) - Zentek Ltd. (TSXV: ZEN) (NASDAQ: ZTEK) ("Zentek" or the "Company"), today announces that its common shares will transition from trading on The Nasdaq Capital Market to the OTC Markets Group on Tuesday, September 2, 2026. This transition follows the receipt by Zentek of a notice from The Nasdaq Stock Market LLC indicating that Zentek's common shares will be delisted from the Nasdaq Capital Market due to non-compliance with Nasdaq's minimum bid price requirement. Zentek intends to request a hearing from Nasdaq to appeal the delisting determination. The hearing will not stay the suspension of trading of Zentek's common shares, and trading of Zentek's common shares on The Nasdaq Capital Market is expected to be suspended at the open of trading on September 2, 2026.
The Company's common shares continue to trade on the TSX Venture Exchange under the symbol ZEN. The TSX Venture Exchange is the Company's primary listing and is unaffected by this determination. Shareholders are not required to take any action.
Zentek has applied to seek approval for its common shares to be quoted on the OTCQX Best Market, the premier tier operated by the OTC Markets Group.
The transition of trading onto the OTC Markets Group is not expected to result in material impacts to Zentek's business or operations.
Zentek will continue to provide updates on business progress and financial results in accordance with applicable Securities and Exchange Commission regulations. Additional information related to this announcement will be included in a Current Report on Form 8-K to be filed with the SEC.
About Zentek Ltd.
Zentek Ltd. is a Canadian intellectual property development and commercialization company advancing a portfolio of graphene-enabled and advanced material technologies across clean air, next-generation materials, and critical minerals. Core platforms are Albany Graphite, ZenGUARD™, and Triera. Albany is the Company's principal critical minerals asset.
For more information:
Mohammed (Moe) Jiwan
Chief Executive Officer, Zentek Ltd.
T: 437-826-3779
E: mjiwan2@zentek.com
www.zentek.com
Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/311986
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.